GC Rieber VivoMega is partnering with OmegaQuant to offer free Omega-3 Index testing at its booth (#3552) during SupplySide West/Fi North America taking place on October 25-26.
GC Rieber VivoMega (Kristiansund, Norway) has announced a partnership with OmegaQuant to offer free Omega-3 Index testing at its booth (#3552) during SupplySide West/Fi North America taking place on October 25-26. The Omega-3 Index is the amount of EPA and DHA in the blood, with an Omega-3 Index of 8% or higher representing the ideal. According to OmegaQuant, most people’s Omega-3 Index is about 6% or lower, but in the U.S. levels of Omega-3 Index are typically 4% or lower.
“We are always thrilled to partner with companies like GC Rieber VivoMega to promote improved health and education around omega-3s,” said Jason Polreis, CEO of OmegaQuant, in a press release. “We hope to see many attendees take advantage of this great opportunity that GC Rieber VivoMega is providing.”
Attendees will also receive samples of the company’s omega-3 concentrates and a follow-up test to measure improvements in Omega-3 Index. This represents a greater than $200 value, says GC Rieber VivoMega. The company also announced that it will be showcasing its Phase II: VivoMega Platinum Sampling Program, which offers its highest concentrations in smaller dosage formats. GC Rieber VivoMega will also be showcasing and sampling its high-concentration vegan Omega-3 from microalgae.
“We want to make a big splash as SSW this year to show our ongoing commitment to excellence. Partnering with OmegaQuant to provide these Omega-3 Index tests, followed by a sample of our products and a second Omega-3 Index test, will show attendees how our products help improve omega-3 levels,” said Christopher Hachey, U.S. Business Development manager at GC Rieber VivoMega, in a press release. "Please join us at the show to learn more about our vegan and marine-derived omega-3 concentrates and our commitment to the industry through sustainable, environmentally friendly practices and human and social development."